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AMPK, a master regulator of metabolic homeostasis, is activated by both 20	  
AMP-dependent and AMP-independent mechanisms. We investigated the 21	  
conditions under which these different mechanisms operate, and their biological 22	  
2	  
	  
implications. We show that, depending on the degree of elevation of cellular 23	  
AMP, distinct compartmentalized pools of AMPK are activated, phosphorylating 24	  
different sets of targets. Low glucose activates AMPK exclusively through the 25	  
AMP-independent, AXIN-based pathway in lysosomes to phosphorylate targets 26	  
such as ACC1 and SREBP1c, exerting early anti-anabolic and pro-catabolic 27	  
roles. Moderate increases in AMP expand this to activation of cytosolic AMPK 28	  
although still AXIN-dependent, while high concentrations of AMP arising from 29	  
severe nutrient stress activates all pools of AMPK independently of AXIN. 30	  
Surprisingly, mitochondrion-localized AMPK is activated, and phosphorylates 31	  
ACC2 and mitochondrial fission factor (MFF), only during severe nutrient stress. 32	  
Our findings reveal a spatiotemporal basis for hierarchical activation of different 33	  
pools of AMPK during differing degrees of severity of stress. 34	  
 35	  
INTRODUCTION 36	  
The AMP-activated protein kinase (AMPK) is a pivotal sensor for monitoring cellular 37	  
nutrient supply and energy status, and plays crucial roles in adaptive responses to 38	  
nutrient availability and falling energy levels1-5. AMPK occurs as heterotrimeric 39	  
complexes containing a catalytic α subunit and regulatory β and γ subunits, with the γ 40	  
subunit providing the binding sites for the regulatory adenine nucleotides AMP, ADP 41	  
and ATP, their occupancy depending on the cellular AMP:ATP and ADP:ATP 42	  
ratios6-8. Binding of AMP causes allosteric activation of AMPK, while binding of 43	  
AMP or ADP enhances phosphorylation of Thr172 on the α subunit by the upstream 44	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kinase liver kinase B1 (LKB1), and inhibits Thr172 dephosphorylation by protein 45	  
phosphatases; all three effects being opposed by binding of ATP9. This represents the 46	  
classical or canonical mechanism for activation. Thr172 can also be phosphorylated 47	  
by a non-canonical, AMP/ADP-independent mechanism in which Thr172 is 48	  
phosphorylated by the alternative upstream kinase Ca2+/calmodulin-dependent protein 49	  
kinase kinase-2 (CaMKK2/CaMKKβ) in response to increases in cellular Ca2+ 50	  
concentration10-12. Glucose starvation of cells has been known for many years to 51	  
activate AMPK13, and was believed to occur exclusively via the canonical mechanism 52	  
involving increases in cellular AMP or ADP. However, this view has been challenged 53	  
by recent findings that AMPK located at the lysosome can be activated by falling 54	  
levels of glucose, both in vivo and in vitro, via an additional AMP/ADP-independent 55	  
mechanism14, 15. This mechanism requires the glycolytic enzyme	  56	  
fructose-1,6-bisphosphate (FBP) aldolase, the vacuolar H+-ATPase (v-ATPase), the 57	  
pentameric Ragulator complex (LAMTOR1-LAMTOR516, 17), and the scaffold 58	  
protein AXIN1 (often referred to simply as AXIN), which binds the upstream kinase 59	  
LKB1. As glucose in the medium is reduced, aldolase associated with the v-ATPase 60	  
becomes progressively unoccupied by FBP, and this transmits the signal of glucose 61	  
shortage to the v-ATPase:Ragulator complex. The latter then undergoes 62	  
conformational changes that allow binding of the AXIN1-LKB1 complex, which in 63	  
turn forms a complex with AMPK at the lysosome. This “super-complex”, referred to 64	  
below as the lysosomal AMPK activation complex, brings LKB1 and AMPK together, 65	  
leading to phosphorylation and activation of the latter4, 14, 18, 19. Besides AMPK 66	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located at the lysosome, subcellular fractionation and fluorescence microscopy 67	  
analyses have shown that AMPK can be localized and activated in other locations 68	  
such as the cytosol, nucleus and mitochondria, both in mammalian cells and in 69	  
yeast20-26. Importantly, N-myristoylation of AMPK-β subunits27, 28 has been shown to 70	  
be necessary for lysosomal localization and activation of AMPK in an 71	  
AMP-independent manner by glucose starvation14, as well as for mitochondrial 72	  
localization and induction of mitophagy in various mammalian cell lines24.  73	  
 74	  
Once activated, AMPK directly phosphorylates multiple targets involved in regulation 75	  
of metabolic processes to maintain energy homeostasis. These effects can be 76	  
categorized as: i) inhibition of anabolism, and ii) stimulation of catabolism, thus 77	  
minimizing ATP consumption and stimulating ATP production respectively3. For 78	  
example, AMPK phosphorylates and inactivates both isoforms of acetyl-CoA 79	  
carboxylase, i.e. ACC1 (on Ser7929) and ACC2 (on Ser22130). These isoforms 80	  
catalyze the same reaction of converting acetyl-CoA to malonyl-CoA, but ACC1 is 81	  
located in the cytosol and is proposed to provide the pool of malonyl-CoA for fatty 82	  
acid synthesis, while ACC2 is located at the mitochondrion and is proposed to provide 83	  
the pool of malonyl-CoA that inhibits carnitine:palmitoyl-CoA acyl transferase-1 84	  
(CPT1) and hence the uptake and subsequent oxidation of fatty acids in 85	  
mitochondria31-33. Therefore, AMPK can both inhibit fatty acid synthesis by 86	  
phosphorylating ACC1 and promote fatty acid oxidation by inhibiting ACC234. 87	  
AMPK also phosphorylates the endoplasmic reticulum-localized form of the 88	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transcription factor sterol regulatory element-binding protein-1c (SREBP-1c) at 89	  
Ser372, to inhibit its proteolytic cleavage and thereby suppress fatty acid	  synthesis at 90	  
the transcriptional level35, while also inhibiting other anabolic pathways such as 91	  
glycogen, rRNA and nucleotide synthesis34, 36, and inhibiting mTORC1 by 92	  
phosphorylating its upstream negative regulator, tuberous sclerosis complex-2 93	  
(TSC2)37, and/or the mTORC1 subunit RAPTOR38. Interestingly, when cells are 94	  
facing shortage of glucose, the lysosomal v-ATPase and Ragulator complex becomes 95	  
involved in AMPK activation and dissociates mTORC1 from the lysosomal surface, 96	  
providing another level of inhibitory regulation of mTORC139, 40. Apart from blocking 97	  
anabolic processes, AMPK stimulates various catabolic processes including glucose 98	  
uptake and autophagy. For example, it phosphorylates TBC1D1 to promote glucose 99	  
uptake in skeletal muscle41, 42. AMPK also directly phosphorylates ULK1 and 100	  
Beclin-1 at multiple sites to initiate autophagy under energy stress43-45. The 101	  
mitochondrial outer membrane-localized mitochondrial fission factor (MFF), which 102	  
promotes mitochondrial fragmentation prior to mitophagy, is also a direct substrate of 103	  
AMPK, thus leading to induction of mitophagy46, 47. Moreover, recent evidence has 104	  
indicated that AMPK is also localized in the nucleus, phosphorylating ten-eleven 105	  
translocation protein 2 (TET2)48, 49. 106	  
 107	  
In this study, we systemically evaluated how compartmentalized pools of AMPK are 108	  
regulated, and how different subcellular targets of AMPK are phosphorylated in 109	  
response to different severities of nutrient or energy stress. Emphasis was placed on 110	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the dependency of AMPK activation on increases in cellular AMP, and AXIN1 as the 111	  
scaffold for the upstream kinase LKB1. We demonstrate that in MEFs starved for 112	  
glucose or livers of mice starved for 16 hr, when AMP:ATP or ADP:ATP ratios 113	  
remained unchanged, AMPK activation occurred exclusively in the lysosomal pool. 114	  
At medium-to-high AMP levels, as seen in HEK293 cells starved for glucose, or in 115	  
MEFs undergoing early phases of severe nutrient starvation (removal of both glucose 116	  
and glutamine from the medium), cytosolic as well as lysosomal AMPK is activated, 117	  
but AXIN1 is still needed to promote LKB1-AMPK association. By contrast, when 118	  
cellular AMP levels are elevated to high levels due to severe nutrient starvation or 119	  
ischemia, mitochondrial AMPK becomes activated independently of AXIN1, 120	  
presumably via conformational changes in AMPK that allow LKB1 to directly 121	  
phosphorylate Thr172. Importantly, we found that AXIN2 (also known as AXIL or 122	  
Conductin), which shows redundancy with AXIN1 in Wnt signaling50, can also 123	  
functionally replace AXIN1 in bridging LKB1 and AMPK. This spatiotemporal 124	  
regulation of AMPK complexes in different compartments may be due to expression 125	  
of different combinations of subunit isoforms, and may have profound physiological 126	  
and pharmacological implications. 127	  
 128	  
RESULTS 129	  
Basal AMP is sufficient for activation of the lysosomal pool of AMPK 130	  
We previously showed that genetic knockout of either AXIN1 or LAMTOR1, critical 131	  
components of the lysosomal AMPK activation complex, blocked AMPK activation 132	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(assessed by phosphorylation of Thr172) in mouse embryo fibroblasts (MEFs) 133	  
deprived of glucose18. We also reported that AMPK activation under these conditions 134	  
was rapid (within 10 minutes) and was not accompanied by any increases in cellular 135	  
AMP:ATP or ADP:ATP ratios14. However, we also found that more severe nutrient 136	  
stress, caused by removal of both glucose and glutamine, caused a delayed activation 137	  
of AMPK (up to 2 hr) that was independent of AXIN1 or LAMTOR114. These results 138	  
suggested that glucose starvation may exclusively activate the lysosomal pool of 139	  
AMPK, whereas complete nutrient withdrawal may activate non-lysosomal pools. To 140	  
address this, we optimized methods to perform subcellular fractionation in MEFs 141	  
(validation shown in Supplementary information, Fig. S1a-c) and systematically 142	  
determined which pools of AMPK (cytosolic, lysosomal, mitochondrial, and nuclear) 143	  
are activated by glucose deprivation. As shown in Fig. 1a and Supplementary 144	  
information, Fig. S1d, Thr172 phosphorylation was only detected in the lysosomal 145	  
fraction, but not in cytosolic, mitochondrial or nuclear fractions from MEFs cultured 146	  
in low glucose (5 mM or below), in which AMP:ATP and ADP:ATP ratios were 147	  
unchanged (Fig. 1b). Similar results were obtained in HEK293T cells (Supplementary 148	  
information, Fig. S1e, f). Subcellular fractionation of liver homogenates from mice 149	  
starved for 16 hr, which showed no changes in adenine nucleotide ratios, also 150	  
indicated that Thr172 phosphorylation was only detected in the lysosomal fraction 151	  
(Fig. 1c, d). Interestingly, we found that under these conditions phosphorylation of 152	  
ACC1, but not ACC2, was increased (Fig. 1e, f; Supplementary information, Fig. 153	  
S1g). Increased phosphorylation at the AMPK sites on SREBP1c, TSC2, Raptor and 154	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HDAC4, but not MFF, also occurred (Fig. 1g). These data suggest that inhibition of 155	  
synthesis of lipid, protein and carbohydrates is an early event during the response to 156	  
glucose starvation, and occurs prior to any energy stress. In addition, phosphorylation 157	  
of Ser660 of TBC1D1 involved in glucose uptake was also detected after glucose 158	  
starvation, indicating an immediately early pro-catabolic activity (Fig. 1g). 159	  
 160	  
It has been well established that AXIN2, which shares the RGS and DIX domains as 161	  
well as the binding sites for β-catenin, GSK3, Diversin, and Smad3, is functionally 162	  
equivalent to AXIN1, although AXIN2 is not expressed ubiquitously like AXIN1 but 163	  
instead in tissue- and developmental-stage-specific patterns50, 51. In the course of 164	  
testing for the generality of the mechanisms linking glucose sensing to AMPK 165	  
activation in various cell lines, we observed that AMPK was still activated by glucose 166	  
starvation in HEK293T cells even when AXIN1 was knocked down (Fig. 1h). 167	  
However, AXIN2 was expressed at a readily detectable level in these cells, compared 168	  
to MEFs, HEK293 cells, and the liver (Supplementary information, Fig. S1h, i), 169	  
implying that in HEK293T cells AXIN2 was compensating for AXIN1 when the latter 170	  
was knocked out or knocked down. Moreover, knockdown of AXIN1 in HEK293T 171	  
cells elevated the levels of AXIN2 (Supplementary information, Fig. S1h). We also 172	  
knocked down AXIN1 in AXIN2-/- HEK293T cells, and found that the activation of 173	  
AMPK by glucose starvation was indeed largely abrogated (Fig. 1h). Similarly, 174	  
introduction of AXIN2 into AXIN1-/- MEFs (in which AXIN2 was almost 175	  
undetectable) led to a significant activation of AMPK upon glucose starvation (Fig. 176	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1i). In conclusion, our results supported that AXIN1 and AXIN2 are functionally 177	  
equivalent in the lysosomal pathway of AMPK activation. 178	  
 179	  
Modest increases in AMP activate cytosolic AMPK in an AXIN1-dependent 180	  
manner 181	  
Surprisingly, unlike in MEFs or mouse liver18, in HEK293 cells in which LAMTOR1 182	  
was knocked down activation of AMPK by glucose starvation was still observed (Fig. 183	  
2a). To reconcile these differences, we performed subcellular fractionation assays in 184	  
HEK293 cells and found that LAMTOR1-independent activation of both cytosolic 185	  
and lysosomal AMPK, which was blocked when AXIN1 was knocked down, was 186	  
observed (Fig. 2b). This evoked previous findings that there were modest increases in 187	  
AMP/ATP and ADP/ATP ratios in HEK293 cells upon glucose removal14, suggesting 188	  
that AXIN1 can also act as a bridge that tethers AMPK and LKB1 in the cytosol when 189	  
AMP is modestly elevated19. In this study, cellular AMP was increased in response to 190	  
glucose removal from 30 µM to 60 µM, with an increase in AMP/ATP ratio from 191	  
0.006 to 0.015 (Fig. 2c), similar to extents observed in MEFs undergoing early phases 192	  
of severe starvation14. Under these conditions, AMPK phosphorylated ACC1 and 193	  
ACC2 in a similar manner to that seen in MEFs upon glucose starvation (Fig. 2d; 194	  
Supplementary information, Fig. S2a). We also used AICAR to mimic a moderate 195	  
increase in AMP in MEFs. MEFs treated with 0.6 mM AICAR yielded an estimated 196	  
intracellular ZMP concentration of 1.2 mM which, given that ZMP is about 40-fold 197	  
less potent than AMP for AMPK activation52, is equivalent to around 50 µM AMP (in 198	  
10	  
	  
addition to about 20 µM endogenous AMP), similar to the concentration estimated in 199	  
HEK293 cells upon glucose starvation (Supplementary information, Fig. S2b). 200	  
Consistently, we found an AXIN1-dependent, LAMTOR1-independent activation of 201	  
both lysosomal and cytosolic AMPK, similar to that observed in HEK293 cells (Fig. 202	  
2e-h; Supplementary information, Fig. S2c, d). Taken together, these results 203	  
suggested that AXIN1 also participates in the activation of cytosolic AMPK when 204	  
AMP levels are moderately increased.  205	  
 206	  
To further confirm that AXIN1 can play a role in bridging LKB1 to AMPK in the 207	  
activation of cytosolic AMPK as well as in the lysosomal pathway, we observed that 208	  
in both lysosomal and cytosolic fractions, the increased LKB1-AMPK interaction 209	  
induced in conditions that caused elevation of AMP to moderate levels was dampened 210	  
in the absence of AXIN1 (Fig. 2i). In vitro reconstitution experiments showed that 211	  
addition of a moderate level of AMP (60 µM) significantly promoted the 212	  
phosphorylation of AMPK by LKB1 in vitro in an AXIN1-dependent manner 213	  
(Supplementary information, Fig. S2e). Taken together, these results demonstrate that 214	  
after moderate elevation of AMP, AXIN1 alone can tether LKB1 to AMPK without 215	  
the necessity for the v-ATPase-Ragulator complex involved in the lysosomal 216	  
pathway.  217	  
 218	  
The mitochondrion-localized ACC2 is phosphorylated by AMPK only after 219	  
severe nutrient stress 220	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We next analyzed the regulation of AMPK and its substrates under severe nutrient 221	  
stress. When MEFs were severely starved or treated with 2 mM AICAR (yielding 3.6 222	  
mM intracellular ZMP, equivalent to around 110 µM AMP (in addition to around 20 223	  
µM endogenous AMP), mimicking the levels of AMP accumulated under severe 224	  
nutrient stress), full activation of AMPK in the cytosolic, lysosomal and 225	  
mitochondrial pools was observed (Fig. 3a, b). Such a full phosphorylation of AMPK 226	  
was also observed in HEK293 and HEK293T cells (Fig. 2a, b; Supplementary 227	  
information, Fig. S1e). Of note, no nuclear AMPK activation could be detected in any 228	  
level of stress (Supplementary information, Fig. S1d). Under these conditions, we 229	  
found that ACC2 was phosphorylated as well as ACC1 (Fig. 3C). Compared with 230	  
ACC1, ACC2 has an additional N-terminal hydrophobic sequence that specifically 231	  
targets it to the mitochondrial outer membrane31 (also validated in Supplementary 232	  
information, Fig. S3a-c). We thus probed the p-ACC signals in cytosolic and 233	  
mitochondrial fractions, and found that the mitochondrial p-ACC could only be 234	  
detected under conditions of severe nutrient stress (Fig. 3d). To obtain unequivocal 235	  
evidence that the p-ACC signals seen after severe nutrient stress was contributed by 236	  
ACC2, we generated ACC1-/- and ACC2-/- MEFs (Fig. S3d). Knockout of ACC2, 237	  
unlike that of ACC1, had no effect on the phosphorylation of ACC upon glucose 238	  
starvation or after a moderate elevation of AMP, but blocked the increase of the 239	  
p-ACC signal in severe nutrient stress (Fig. 3e). Moreover, we found that levels of 240	  
malonyl-CoA were decreased by 50% in MEFs starved for glucose only, and were 241	  
further decreased by up to 90% under severe nutrient starvation, to a similar extent as 242	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the reduction caused by treatment with TOFA (a pan-ACC inhibitor), without any 243	  
significant change on its precursor, acetyl-CoA (Fig. 3f). Consistently, both ACC1 244	  
and ACC2, along with AMPK from all the fractions, were phosphorylated in liver of 245	  
mice subjected to hepatic ischemia, when a large, 22-fold increase of AMP:ATP ratio 246	  
was detected (equivalent to an increase of AMP from 20 µM to 475 µM, estimated as 247	  
described previously53, Fig. 3g, h; Supplementary information, Fig. S3e); a further 248	  
decrease of malonyl-CoA, compared with that seen after 16-hr starvation, was also 249	  
observed (Fig. 3i). We found that when there were large increases in AMP, knockout 250	  
of AXIN1 or LAMTOR1 did not block the phosphorylation of ACC1, ACC2 or AMPK 251	  
in either the cytosolic, lysosomal or mitochondrial fractions (Supplementary 252	  
information, Fig. S3f-i).  253	  
 254	  
ACC1 and ACC2 contain very similar AMPK substrate recognition motifs54 (which is 255	  
why phospho-specific antibodies recognize both), but vary in their subcellular 256	  
locations. We hypothesized that the targets of AMPK may be regulated in a 257	  
spatiotemporal manner under different stress conditions. To test this, we replaced the 258	  
endogenous AMPK-β subunits with modified forms that target the complex to 259	  
specific locations. It is known that N-myristoylation is required for AMPK association 260	  
with intracellular membranes such as the lysosome14 and the mitochondrion24. We 261	  
generated two fusion constructs with modifications at the N-terminus of the β1 262	  
subunit: either adding the LAMP2 (for tethering to the lysosomal surface, referred to 263	  
as lyso-β1), or TOMM20 (for tethering to mitochondrial outer membrane, referred to 264	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as mito-β1), and also the β1-G2A mutation (preventing N-myristoylation, referred to 265	  
as cyto-β1) (diagrammed in Fig. 3j). Before reintroduction of the engineered 266	  
constructs to cells, we knocked out the β subunits (β1 and β2) of AMPK in HEK293T 267	  
cells, generating AMPKβ-DKO cells (validation in Supplementary information, Fig. 268	  
S4a). Lyso-β1, mito-β1 and cyto-β1 were then individually re-introduced to the 269	  
AMPKβ-DKO cells. As shown in Supplementary information, Fig. S4b, the 270	  
engineered β1 subunits assembled into heterotrimeric AMPK complexes like the 271	  
wild-type AMPK-β1, and were successfully localized as expected, as validated by 272	  
immunostaining (Supplementary information, Fig. S4c). We next treated the cells 273	  
with A-769662, a β1-specific activator55, to cause a compartmentalized activation of 274	  
AMPK (validated in Supplementary information, Fig. S4d). We found that in 275	  
lyso-β1-expressing cells, only cytosol-localized ACC1 can be phosphorylated in 276	  
response to A-769662 treatment (Fig. 3k). By contrast, in mito-β1- and 277	  
cyto-β1-expressing cells, both the cytosol-localized ACC1 and the 278	  
mitochondrion-localized ACC2 were phosphorylated (Fig. 3k). Therefore, 279	  
mitochondrion-localized ACC2 seems to be specifically phosphorylated under severe 280	  
nutrient stress, in which mitochondrial and cytosolic AMPK are also fully activated. 281	  
Supporting this, we found that the mitochondrial fission factor MFF, another 282	  
well-characterized mitochondrion-localized AMPK substrate47, was phosphorylated in 283	  
a similar manner to ACC2 (Fig. 1g).  284	  
 285	  
Roles of AMP in the hierarchical activation of AMPK 286	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We postulated that upon starvation for glucose only, basal AMP might act as a 287	  
necessary cofactor for AMPK activation via the lysosomal pathway, while elevated 288	  
AMP may bind to additional sites on AMPK. Indeed, when the AMPK-γ1 mutant 289	  
D317A, which affects the “non-exchangeable” site for AMP (site 4), was 290	  
re-introduced into HEK293T cells with all γ subunits (γ1 to γ3) knocked out 291	  
(AMPKγ-TKO, generated as shown in Supplementary information, Fig. S4e), 292	  
activation of AMPK upon glucose starvation was severely dampened (Fig. 4a), 293	  
consistent with our previous finding that the AMP-promoted interaction between 294	  
LKB1 and AMPK was impaired by this mutant19. We also introduced the R531G 295	  
mutant, in which the exchangeable site for AMP (site 38) is disrupted, into 296	  
AMPKγ-TKO cells, and found that the phosphorylation of lysosomal AMPK upon 297	  
glucose starvation remained unaffected, whereas the cytosolic and mitochondrial 298	  
AMPK phosphorylation under moderate and high AMP levels was blocked (Fig. 4b). 299	  
Similarly, phosphorylation of ACC2 was blocked in the R531G-expressing cells (Fig. 300	  
4c). We also determined whether it is indeed AMP itself that mediated such effects by 301	  
knocking out adenylate kinase 1 (AK1, which catalyzes the conversion of 2 ADP to 1 302	  
ATP and 1 AMP) in MEFs (Supplementary information, Fig. S4f). Indeed, we found 303	  
that knockout of AK1 significantly dampened the activation of mitochondrial- and 304	  
cytosolic-localized AMPK, and the phosphorylation of ACC2 under severe nutrient 305	  
stress (Fig. 4d; Supplementary information, Fig. S4g).  306	  
 307	  
DISCUSSION 308	  
15	  
	  
In this study, we have systemically determined how the differentially localized 309	  
AMPK complexes are regulated to affect distinct target phosphorylation in response 310	  
to different stresses (Fig. 4e). Under conditions of glucose starvation that did not 311	  
elevate cellular AMP:ATP or ADP:ATP ratios, only lysosomally localized AMPK 312	  
was activated, exclusively through the lysosomal pathway. However, when AMP was 313	  
moderately elevated, cytosolic AMPK was also activated in addition to lysosomal 314	  
AMPK. Activation induced by moderate increases in AMP was not mediated via the 315	  
lysosomal pathway, because knockout of LAMTOR1 (a subunit of the Ragulator 316	  
complex) had no effect, although activation was still dependent on AXIN1. In support 317	  
of this, moderately elevated AMP promoted the formation of a complex between 318	  
AXIN1, LKB1 and AMPK. Interestingly, mitochondrial AMPK was not activated by 319	  
moderate increases in AMP, but only in response to more severe nutrient stress when 320	  
there were larger increases in AMP. One possible explanation for this is that the 321	  
concentrations of ATP are higher in the vicinity of mitochondria, inhibiting the 322	  
activation of AMPK by AMP. However, when cellular AMP is elevated to higher 323	  
levels during severe nutrient stress or ischemia, mitochondrial AMPK becomes 324	  
activated independently of AXIN1, phosphorylating the mitochondrially localized 325	  
substrates, ACC2 and MFF. 326	  
  327	  
Basal AMP is believed to be maintained at low levels by the freely reversible 328	  
adenylate kinase reaction (2ADP ↔ ATP + AMP), with the high ATP:ADP ratio in 329	  
unstressed cells driving the reaction from right to left, i.e. towards ADP and away 330	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from AMP. AMP is thought to be constantly bound as a cofactor to site 4 of the 331	  
AMPK-γ subunit7, 8, perhaps rendering the AMPK complex ready for activation 332	  
through the aldolase-v-ATPase-Ragulator pathway when glucose runs low. Although 333	  
AXIN is required for activation of both lysosomal and cytosolic AMPK, increases in 334	  
AMP are required for activation of cytosolic AMPK. A possible explanation for this is 335	  
that the presence of Ragulator and v-ATPase on the lysosome alters the conformation 336	  
of the intrinsically disordered protein AXIN that can form various intramolecular 337	  
loops56, 57, such that it is more accessible to AMPK even at basal levels of AMP. By 338	  
contrast, in the cytosol, AXIN does not come into contact with the 339	  
Ragulator:v-ATPase complex, so that only when AMP is bound at a site additional to 340	  
site 4 (most likely site 3, supported by the results obtained using the R531G mutant) 341	  
which likely causes conformational changes therein58, 59, AXIN and LKB1 forms a 342	  
complex with cytosolic AMPK. Finally, when cells are subjected to severe nutrient 343	  
stress, AMP is increased to such high levels that AMPK is fully occupied by AMP, 344	  
and LKB1 does not require AXIN to bind AMPK. 345	  
 346	  
AMPK is composed of three subunits, each occurring as more than one isoform (α1, 347	  
α2; β1, β2; γ1, γ2, γ3). These isoforms, some of which are expressed in a 348	  
tissue-specific manner, can form up to twelve different heterotrimeric combinations60. 349	  
It has been proposed that these different isoform combinations target AMPK to 350	  
different subcellular locations3, 61, 62. Indeed, studies have shown that isoform-specific 351	  
activations of AMPK lead to different effects on metabolic controls. For example, 352	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compared to AICAR, A-769662 (the β1-specific activator) only mildly stimulated 353	  
fatty acid oxidation, although robustly inhibited fatty acid synthesis63. The AMPK 354	  
complex containing the γ1-D317A mutant showed strong preference for cytosolic 355	  
presence64, and failed to stimulate fatty acid oxidation despite its chronic activity65. 356	  
Based on the results in this paper, it is conceivable that different thresholds of stress 357	  
are involved in triggering differentially localized AMPK heterotrimers, and that 358	  
different heterotrimeric AMPK complexes might have specificity for targets due to 359	  
different subcellular locations. Indeed, it is already known that AMPK complexes 360	  
containing γ1, γ2 and γ3 differ in their sensitivity to activation by AMP and ADP9. 361	  
 362	  
Our current study has shown that an immediate role of AMPK activation is to 363	  
phosphorylate and inhibit factors involved in anabolic pathways including ACC1, 364	  
SREBP1c, HDAC4, TSC2, and Raptor. It is interesting that ACC2 is phosphorylated 365	  
only under conditions of more severe nutrient stress and ischemia, when there are 366	  
larger increases in AMP. This indicates that fatty acid oxidation, a catabolic pathway, 367	  
is increased during more severe stress, while fatty acid synthesis is shut down during 368	  
a mild stress, i.e. lack of glucose. Since glucose is a major precursor for fatty acid 369	  
synthesis in many cell types, it might make sense for this pathway to be switched off 370	  
when there is reduced availability of glucose. By contrast, ACC2 appears to be 371	  
phosphorylated only under conditions of more severe nutrient stress (lack of both 372	  
glucose and glutamine), when fatty acid oxidation may need to be facilitated as an 373	  
alternate energy source. It is also interesting to note that ULK1 and Beclin-1 become 374	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phosphorylated at an early stage of glucose starvation44, exactly the time point that 375	  
AMPK is activated14, although autophagy takes place only at a later stage in which 376	  
additional factors such as accumulated ammonia, and the increased acetylation of 377	  
VPS34 are involved in the formation of autophagosomes66, 67. Consistently, we also 378	  
showed that the mitochondrial fission factor MFF, which promotes the formation of 379	  
fragmented mitochondria prior to mitophagy/autophagy is only phosphorylated after 380	  
severe starvation. Taken together, differently localized AMPK pools are differentially 381	  
regulated, with AMP-dependent and AMP-independent pathways operating in a 382	  
spatiotemporal manner. Our paper supports the view that glucose sensing by the 383	  
lysosomal AMPK activation pathway serves to act as a surveillance system 384	  
monitoring the availability of glucose and switching off anabolic pathways, many of 385	  
which require glucose for the provision of precursors. We also suggest that 386	  
pharmacological activation of all pools of AMPK might have adverse effects on 387	  
cellular and tissue physiology, and that new strategies may be required to activate the 388	  
appropriate spatial and temporal pools of AMPK in order to develop effective and 389	  
safe drugs for treating metabolic diseases. 390	  
 391	  
Although we have demonstrated that different severities of nutritional stress modulate 392	  
different pools of AMPK and different downstream targets, contingent on different 393	  
cellular levels of AMP, in some cases it remains unclear how this relates to the 394	  
physiological roles of the targets. For example, we found that ACC2 is 395	  
phosphorylated only after severe nutrient stress in MEFs, and is not phosphorylated in 396	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liver even from overnight-starved mice. However, fatty acid oxidation has been 397	  
reported to be enhanced in mice that were starved overnight68. Thus, elevated fatty 398	  
acid oxidation under mild starvation may be caused by processes other than ACC2 399	  
phosphorylation. Indeed, it has been reported that increased circulating fatty acid, 400	  
released primarily by adipose tissues69, and enhanced expression of CPT170, may be 401	  
involved under these circumstances. Another interesting issue is that ULK1 and 402	  
Beclin-1 are among the substrates that are phosphorylated by AMPK immediately 403	  
after glucose starvation, yet autophagy does not take place upon short-term glucose 404	  
starvation. It therefore remains unclear what the roles of the phosphorylation of ULK1 405	  
and Beclin-1 by AMPK exert beyond autophagy, although ULK1/2 have been shown 406	  
to play a role in modulating glucose metabolic fluxes, independently of autophagy71. 407	  
 408	  
MATERIALS AND METHODS 409	  
Antibodies 410	  
Rabbit polyclonal antibody against LAMTOR1 was raised and validated as described 411	  
previously18, and was diluted 1:100 for immunoprecipitation (IP) or 1:500 for 412	  
immunoblotting (IB). Rabbit anti-phospho-AMPKα-T172 (cat. #2535, 1:1000 for IB), 413	  
anti-AMPKα (cat. #2532, 1:1000 for IB), anti-phospho-ACC-Ser79 (cat. #3661, 414	  
1:1000 for IB), anti-ACC (cat. #3662, 1:1000 for IB), anti-LKB1 (cat. #3047, 1:1000 415	  
for IB), anti-AMPKβ1/2 (cat. #4150, 1:1000 for IB), anti-AMPKγ1 (cat. #4187, 416	  
1:1000 for IB), anti-AMPKγ2 (cat. #2536, 1:1000 for IB), anti-AMPKγ3 (cat. #2550, 417	  
1:1000 for IB), anti-AXIN1 (cat. #2074, 1:1000 for IB), anti-AXIN2 (cat. #2151, 418	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1:1000 for IB), anti-ACC1 (cat. #4190, 1:1000 for IB and 1:100 for IP), anti-ACC2 419	  
(cat. #8578, 1:1000 for IB and 1:25 for IP), anti-phospho-SREBP1c-S372 (cat. #9874, 420	  
1:500 for IB), anti-phospho-Raptor-S792 (cat. #2083, 1:1000 for IB), anti-Raptor (cat. 421	  
#2280, 1:1000 for IB), anti-phospho-TSC2-S1387 (cat. #2280, 1:1000 for IB), 422	  
anti-TSC2 (cat. #4308, 1:1000 for IB), anti-phospho-HDAC4-S246 (cat. #3443, 423	  
1:1000 for IB), anti-HDAC4 (cat. #7628, 1:1000 for IB), anti-phospho-MFF-S146 424	  
(cat. #49281, 1:500 for IB), anti-MFF (cat. #86668, 1:1000 for IB), 425	  
andi-phospho-TBC1D1-S660 (cat. #6928, 1:500 for IB), anti-TBC1D1 (cat. #4629, 426	  
1:1000 for IB), anti-phospho-ULK1-S555 (cat. #5869, 1:1000 for IB), 427	  
anti-phospho-Beclin-1-S93 (cat. #14717, 1:1000 for IB), anti-Beclin-1 (cat. #3495, 428	  
1:1000 for IB), anti-COXIV (cat. #4850, 1:1000 for IB and 1:200 for IF), anti-PDI 429	  
(cat. #3501, 1:1000 for IB), anti-Lamin B1 (cat. #13435, 1:1000 for IB), 430	  
anti-β-tubulin (cat. #2128, 1:1000 for IB), anti-HA-tag (cat. #3724, 1:200 for IF), 431	  
mouse anti-Myc-tag (cat. #2276, 1:1000 for IB), and HRP-conjugated mouse 432	  
anti-rabbit IgG (conformation specific, cat. #5127, 1:2000 for IB) antibodies were 433	  
purchased from Cell Signaling Technology. Rabbit anti-AK1 (cat. 14978-1-AP, 1:500 434	  
for IB) and rabbit anti AXIN2 (cat. 20540-1-AP, 1:1000 for IB, only for 435	  
Supplementary information, Fig. S1h) were purchased from Proteintech. Mouse 436	  
anti-LAMP1 (cat. ab13523, 1:200 for IF), anti-AMPKα (cat. ab80039, 1:100 for IP) 437	  
and rat anti-LAMP2 (cat. ab13524, 1:1000 for IB) were purchased from Abcam. The 438	  
ANTI-FLAG® M2 Affinity Gel (cat. A2220) and rabbit anti-ULK1 (cat. A7481, 439	  
1:1000 for IB) were purchased from Sigma. Goat anti-AXIN (cat. sc-8567, 1:100 for 440	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IP and 1:60 for IF), rabbit anti-SREBP1 (cat. sc-366, 1:1000 for IB), and mouse 441	  
anti-HA (cat. sc-7392, 1:2000 for IB and 1:200 for IF) antibodies were purchased 442	  
from Santa Cruz Biotechnology. The HRP-conjugated goat anti-mouse IgG (cat. 443	  
115-035-003, 1:5000 for IB) and HRP-conjugated goat anti-rabbit IgG (cat. 444	  
111-035-003, 1:5000 for IB) antibodies were purchased from Jackson 445	  
ImmunoResearch. 446	  
 447	  
Bacterial and virus strains 448	  
Stbl3 (cat. C737303, for transformation of pBOBI- and pLL3.7-based constructs), 449	  
BL21 (DE3, cat. C600003, for transformation of pET-based constructs) and DH5α 450	  
(cat. 18258012, for transformation of other constructs) competent cells were 451	  
purchased from Thermo Fisher Scientific. 452	  
 453	  
Chemicals and recombinant proteins 454	  
TOFA (cat. sc-200653A) was purchased from Santa Cruz Biotechnology. AICAR (cat. 455	  
A9978), AMP (cat. 01930) and LKB1 complex (cat. SRP0246) were purchased from 456	  
Sigma. A-769662 (cat. S2697) was purchased from Selleck. Lysosome Isolation Kit 457	  
(cat. LYSISO1) was purchased from Sigma. 458	  
 459	  
Cell lines 460	  
HEK293T cells (cat. CRL-3216) were obtained from ATCC, and HEK293 cells (cat. 461	  
CRL-1573) were obtained from Invitrogen. LAMTOR1F/For AXINF/F MEFs were 462	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established by introducing SV40 T antigen into primary cultured embryonic cells 463	  
from a litter of corresponding mice. 464	  
 465	  
Oligonucleotides 466	  
The siRNAs against human AXIN1 and LAMTOR1 were constructed and validated 467	  
as described previously18, 19. The sequence for each sgRNA is as follows (forward 468	  
strand only):  469	  
5’-	   TAGGATCGGAAACTTACTAGTGG -3’ and 5’-	  470	  
GGCTCAGGTTAACTAACGT 471	  
TAGG -3’ for human PRKAB1,  472	  
5’-	   TTTAGGCAGTGCTTGAGCATAGG -3’ and 5’-	  473	  
CGGCCACTTAGTATATCTGT 474	  
GGG -3’ for human PRKAB2,  475	  
5’-	  CTGATTTATAGTAGCGGTGCAGG-3’ for human PRKAG1,  476	  
5’-	  GATGCAGTCACTCCACGCTCTGG -3’ and 5’-	  CGGTGGCACCGAAGCTGC 477	  
CAGG-3’ for human PRKAG2,  478	  
5’-AGCCCGTGCGCTCAATCTTCTGG-3’ and 5’-TGGGGCCTGTTTGGTTAATA 479	  
GGG-3’ for human PRKAG3,  480	  
and 5’-CACCGAGTCAGCTCTGGATCGGAGA-3’ for mouse Ak1. 481	  
 482	  
Animals 483	  
AXINF/F, LAMTOR1F/F mice were generated and maintained as described18. 484	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ACC1-floxed mouse (Stock No. 030954, The Jackson Laboratory) was a generous gift 485	  
from Prof. Jay Horton (UT Southwestern Medical Center), and the ACC2-/- mouse 486	  
from Prof. Tian Xu (Institute of Developmental Biology and Molecular Medicine, 487	  
Fudan University). Wildtype C57BL/6J mice were purchased from Beijing Vital 488	  
River Laboratory Animal Technology Co., Ltd.,	   and were housed at Animal Core 489	  
Facility. Male littermate mice of 6-week old were used in this study. Mice were 490	  
housed with free access to water and standard diet (65% carbohydrate, 11% fat, 24% 491	  
protein). Protocols for all animal experiments were approved by the Institutional 492	  
Animal Care and the Animal Committee of Xiamen University. 493	  
 494	  
Mouse studies 495	  
For starvation, the diet was withdrawn from the cage at 5 p.m. and mice were 496	  
sacrificed at 9 a.m. the next day by cervical dislocation. For hepatic ischemia, a 497	  
surgery was performed as described previously72, with some modifications. Mice 498	  
were anesthetized with pentobarbital sodium solution (100 mg/kg) by intraperitoneal 499	  
injection and were placed on a heating plate set at 37 °C. Mouse abdomen was gently 500	  
opened (from the mid-abdomen to the xiphoid) to expose the liver, and its intestine 501	  
was covered by moisten gauze to prevent from drying. The portal vein, hepatic artery, 502	  
and bile duct were then cross-clamped by an atraumatic clip at a place just above the 503	  
branching to the right lateral lobe to subject the median and the left lateral lobes to 504	  
ischemia. Mice that went through same surgery but did not undergo cross-clamping 505	  
on blood vessel and bile duct were considered as sham. Unless stated otherwise, liver 506	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tissues were dissected and instantly frozen in liquid nitrogen for immunoblotting, and 507	  
were freeze-clamped for metabolites extraction and fractionation. 508	  
 509	  
Plasmids 510	  
Point mutations on AMPK-γ1 (D317A), AMPK-γ2 (R531G) and AMPK-β1 (G2A) 511	  
were performed by a PCR-based site-directed mutagenesis method using PrimeSTAR 512	  
HS polymerase (Takara). Expression plasmids for various proteins were constructed 513	  
in the pcDNA3.3 vector for transient transfection (ectopic expression), in pBOBI for 514	  
lentivirus packaging (stable expression). PCR products were verified by sequencing 515	  
(Invitrogen, China). The lentivirus-based vector pLL3.7 was used for expression of 516	  
siRNA in HEK293T and HEK293 cells.  517	  
 518	  
CRISPR/Cas9 knockout cell lines  519	  
Genes were deleted in HEK293T cells (human PRKAB1, PRKAB2, PRKAG1, 520	  
PRKAG2, and PRKAG3) or MEFs (mouse Ak1) using the CRISPR-Cas9 system. 521	  
Targeting nucleotides were designed using http://crispr.mit.edu. Oligonucleotides of 522	  
human PRKAG1 were inserted into pX260 vector, human PRKAB1, PRKAB2, 523	  
PRKAG2, and PRKAG3 into pX330 vector, and mouse AK1 into lentiCRISPRv2 524	  
vector. The individual constructs were then subjected to transfection of HEK293T 525	  
cells (pX260 and pX330) followed by single-cell sorting into 96-well dishes, or 526	  
lentivirus packaging (lentiCRISPRv2) using HEK293T cells. In both conditions, cells 527	  
were transfected with 3 µg of DNA with Lipofectamine 2000 (Invitrogen, Cat. 528	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11668-027) per well of a 6-well plate. Clones were expanded and evaluated for 529	  
knockout status by sequencing. 530	  
 531	  
Cell culture, transient transfection and lentivirus Infection 532	  
HEK293T, HEK293 and MEFs were maintained in Dulbecco’s modified Eagle’s 533	  
medium (DMEM, Gibco, cat. 11965) supplemented with 10% fetal bovine serum 534	  
(FBS), 100 IU penicillin, 100 mg/ml streptomycin at 37 °C in a humidified incubator 535	  
containing 5% CO2. Polyethylenimine (Polysciences, Inc., Cat. #23966) at a final 536	  
concentration of 10 µM was used to transfect HEK293T cells. Total DNA for each 537	  
plate was adjusted to the same amount by using relevant empty vector. Transfected 538	  
cells were harvested at 24 hr after transfection. Lentiviruses for infection of the MEFs 539	  
were packaged in HEK293T cells using Lipofectamine 2000 transfection. At 30 hr 540	  
post transfection, medium was collected and added to the cells. The cells were 541	  
incubated for another 24 hr. LAMTOR1F/For AXINF/F MEFs were established by 542	  
introducing SV40 T antigen into primary cultured embryonic cells from a mouse litter. 543	  
LAMTOR1-/- or AXIN-/- MEFs were generated by infecting LAMTOR1F/F or AXINF/F 544	  
MEFs with adenovirus expressing Cre recombinase for 12 hr. The infected cells were 545	  
then incubated in fresh DMEM for another 8 to 10 hr before further treatments. Cells 546	  
were verified to be free of mycoplasma contamination and authenticated by STR 547	  
sequencing.  548	  
For glucose starvation, cells were rinsed twice with PBS, and then incubated in 549	  
glucose-free DMEM (Gibco, cat. 11966) supplemented with 10% FBS and 1 mM 550	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sodium pyruvate (Gibco, cat. 11360) for desired periods of time at 37 °C. For 551	  
starvation for glucose plus glutamine, cells were incubated in DMEM with 5 mM 552	  
glucose overnight, and then incubated for desired periods of time in fresh DMEM 553	  
lacking glucose, glutamine, phenol red or pyruvate (Gibco cat. A14430-01), in which 554	  
1 mM pyruvate was added, with or without Glutamax™ (Gibco cat. 35050-038) and 555	  
D-glucose (Gibco cat. A2494001), all without FBS. 556	  
 557	  
Subcellular fractionation. 558	  
All buffers used for subcellular fractionation contains protease inhibitor cocktail 559	  
(Sigma, cat. P8340). 560	  
Lysosomes were purified by Lysosome Isolation Kit according to the manufacturer’s 561	  
instructions, with minor modifications. Briefly, cells from sixty 10-cm dishes (60-80% 562	  
confluence) were collected by direct scrapping at room temperature, followed by 563	  
centrifugation for 5 min at 500 g at 37 °C. Cells were resuspend in 7 ml of 1× 564	  
Extraction Buffer at room temperature. For isolating lysosomes from mouse livers, 565	  
some 500 mg of frozen liver tissue was directly homogenized in 7 ml of ice-cold 1× 566	  
Extraction Buffer. The cells/liver homogenates were then dounced in a 7-ml Dounce 567	  
homogenizer (Sigma, cat. P0610) for 120 strokes on ice followed by centrifuging for 568	  
10 min at 1,000 g, 4 °C, yielding post-nuclear supernatants (PNS). The PNS were 569	  
then centrifuged for 20 min at 20,000 g and the pellets were suspended in 1× 570	  
Extraction Buffer by gentle pipetting, generating Crude Lysosomal Fractions (CLF). 571	  
The volume of CLF was adjusted to 2.4 ml and then equally divided into six 1.5 mL 572	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Eppendorf tubes (400 µl per tube). 253 µl of OptiPrep and 137 µl of 1× OptiPrep 573	  
Dilution Buffer were added to each CLF, and mixed by gentle pipetting. The mixtures 574	  
were defined as the Diluted OptiPrep Fraction (DOF). Each DOF (0.8 ml) was loaded 575	  
onto an 11 × 60 mm centrifuge tube at the top of 27% (0.4 ml) and 22.5% (0.5 ml) 576	  
OptiPrep solution cushions, and then overlaid with 16% (1 ml), 12% (0.9 ml) and 8% 577	  
(0.3 ml) OptiPrep solutions. The tubes were then centrifuged on a SW60 Ti rotor 578	  
(Beckman) at 150,000 g for 4 hr at 4 °C, and the fractions at the top of 12% OptiPrep 579	  
solution were collected as the crude lysosome fractions. The fractions were diluted 580	  
with two volumes of PBS, followed by centrifugation at 20,000 g for 20 min. The 581	  
sediment was the lysosome fraction. 582	  
Mitochondria were purified as described previously73, with minor modifications. 583	  
Briefly, forty 10-cm dishes of regularly cultured, severely starved or AICAR-treated 584	  
cells (60-80% confluence), or sixty 10-cm dishes of glucose-starved cells were 585	  
collected by direct scrapping at room temperature, followed by centrifugation for 5 586	  
min at 500 g at 37 °C. Cells were then resuspended in 20 ml of ice-cold IBcells-1 587	  
buffer (225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA and 30 mM Tris-HCl, pH 588	  
7.4). For isolating mitochondria from mouse livers, some 500 mg of frozen liver was 589	  
directly homogenized in 10 ml of IBliver-1 buffer (225 mM mannitol, 75 mM sucrose, 590	  
0.5% BSA, 0.5 mM EGTA and 30 mM Tris-HCl, pH 7.4). Cells or liver homogenates 591	  
were then dounced in a 40-ml Dounce homogenizer (Sigma, cat. D9188) for 100 592	  
strokes, followed by two times of centrifugation for 5 min at 600 g (for cells) or 740 g 593	  
(for liver tissues) at 4 °C. The supernatants were then collected and centrifuged for 10 594	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min at 7,000 g (for cells) or 9,000 g (for liver tissues) at 4 °C. The pellets were then 595	  
washed with 20 ml of ice-cold IBcells-2 buffer (for cells, 225 mM mannitol, 75 mM 596	  
sucrose and 30 mM Tris-HCl pH 7.4) or ice-cold IBliver-2 buffer (for liver tissues, 597	  
IBcells-2 buffer supplemented with 0.5% BSA) twice. The suspensions were first 598	  
centrifuged at 7,000 g (for cells) or 10,000 g (for liver tissues), and were centrifuged 599	  
again at 10,000 g, both for 10 min at 4 °C. Note that for liver tissues, the pellets 600	  
subjected to the second time of centrifugation were resuspended in 20 ml of ice-cold 601	  
IBcells-2. The pellets were then resuspended in 2 ml of ice-cold MRB buffer (250 mM 602	  
mannitol, 5 mM HEPES pH 7.4 and 0.5 mM EGTA), and were loaded on top of 10 ml 603	  
of Percoll medium (225 mM mannitol, 25 mM HEPES pH 7.4, 1 mM EGTA and 30% 604	  
Percoll (v/v)) in 14 × 89-mm centrifuge tubes (Beckman, ref. 344059). Tube were 605	  
then centrifuged on a SW41 rotor (Beckman) at 95,000 g for 0.5 hr at 4 °C, and the 606	  
dense band located approximately at the bottom of each tube was collected. The 607	  
collected fractions were diluted with 10 volumes of MRB buffer, followed by 608	  
centrifugation at 6,300 g for 10 min at 4 °C, and washed with 2 ml of MRB buffer, 609	  
followed with centrifugation at 6,300 g for 10 min at 4 °C. The pellets were pure 610	  
mitochondria. 611	  
Cytosol was purified as described74. Briefly, some 0.15 g of each freshly excised liver 612	  
tissue, or ten 10-cm dishes of cells were homogenized in 800 µl of the 613	  
homogenization buffer (HB) containing 250 mM sucrose, 3 mM imidazole, pH 7.4. 614	  
Homogenates were then passed through a 22-G needle attached to a 1-ml syringe for 615	  
six times, and were then centrifuged at 2,000 g for 10 min to yield PNS. PNS samples 616	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were then loaded on to the top of 11 × 60-mm centrifuge tubes that have been loaded 617	  
sequentially with 1 ml of 40.6% sucrose (dissolved in HB), 1 ml of 35% sucrose 618	  
(dissolved in HB), and 1 ml of 25% sucrose (dissolved in HB). Tubes were then 619	  
centrifuged on an SW60 Ti rotor (Beckman) at 35,000 rpm for 1 hr at 4 °C, and the 620	  
top fractions (about 200 µl) were collected as cytosolic fraction. 621	  
Fractionation of nucleus was performed as described previously19. Briefly, cells were 622	  
homogenized in Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 623	  
mM EGTA, and 0.15% NP-40) and placed in ice for 15 min. The homogenates were 624	  
centrifuged at 12,000 g for 1 min at 4 °C. The pellets were washed three times with 625	  
Buffer A and then resuspended in Buffer B (20 mM HEPES, pH 7.9, 0.4 mM NaCl, 1 626	  
mM EDTA, 1 mM EGTA, 0.5% NP-40) and sonicated at 4 °C. Cellular debris was 627	  
removed by centrifugation at 12,000 g for 30 min at 4 °C, and the supernatant was 628	  
nuclear fraction. 629	  
 630	  
Protein production 631	  
AXIN1, and AMPK complexes were expressed and purified in E. coli as described 632	  
previously19. Briefly, full length AXIN1 was cloned into pET32a vector and 633	  
transformed into the E. coli strain BL21 (DE3). The transformed cells were induced 634	  
with 0.1 mM IPTG at an optical density of 0.4 at 600 nm (for AMPK, to 1.0 at 600 635	  
nm). After growing for 4 hr at 16 °C (for AMPK, growing for 16 hr), the cells were 636	  
collected, homogenized in a buffer (50 mM sodium phosphate, pH 7.4, 150 mM NaCl, 637	  
1% Triton X-100, 5% glycerol), and sonicated. Cell debris was removed by 638	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centrifugation. The supernatant was collected and applied to ultracentrifugation at 639	  
150,000 g for 30 min, followed by purification of expressed protein with Nickel 640	  
affinity gel and washed by 50 mM sodium phosphate, pH 7.4, 150 mM NaCl. The 641	  
protein was eluted from the affinity resin by 50 mM sodium phosphate, pH 7.4, 150 642	  
mM NaCl, 250 mM imidazole and concentrated to about 3 mg/ml before further 643	  
purification by gel filtration (Superdex-200, GE Healthcare). The buffer for gel 644	  
filtration contained 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5% glycerol and 1 mM 645	  
DTT. 646	  
 647	  
In vitro AMPK phosphorylation assay  648	  
Bacterially expressed and purified AMPK (800 ng) was incubated with active 649	  
LKB1/MO25/STRAD complex (200 ng) at 32 °C for 15 min in a kinase buffer 650	  
containing 5 mM ATP with or without 60 µM AMP and 1 µg of AXIN1. 651	  
Phosphorylation of AMPK was determined by immunoblotting. 652	  
 653	  
Immunoprecipitation (IP) and immunoblotting 654	  
IP of endogenous AMPKα was performed as described previously19, and was also 655	  
used for IP ACC1 and ACC2, although with some modifications. Briefly, cells of one 656	  
15-cm dish (grown to 80% confluence) or 50 mg liver (for each lane) were collected 657	  
and lysed with 500 µl of ice-cold lysis buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 658	  
1 mM EGTA, 1% Triton X-100, 1 mM β-glycerolphosphate, with protease inhibitor 659	  
cocktail. Note, note that 150 mM NaCl was used for IP of ACC1 and ACC2, and 50 660	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mM NaCl was used for IP of AMPKα. Lysates were incubated with respective 661	  
antibodies for 4 hr (ACC1 and ACC2) or overnight (AMPKα). Protein aggregates 662	  
were pre-cleared by centrifugation at 20,000g for 10 min, and protein A/G beads 663	  
(1:100) were then added into the lysates and mixed for another 1 (for ACC1 and 664	  
ACC2) to 3 hr (for AMPKα). The beads were washed with 100 times volume of lysis 665	  
buffer for 3 times at 4  °C and then mixed with an equal volume of 2× SDS sample 666	  
buffer for immunoblotting.  667	  
To analyze the levels of p-AMPKα and p-ACC in MEFs, cells grown to 70-80% 668	  
confluence in a well of a 6-well dish were lysed with 250 µl of ice-cold lysis buffer. 669	  
The lysates were then centrifuged at 20,000 g for 10 min at 4 °C and an equal amount 670	  
of 2× SDS sample buffer was into each supernatant. The levels of p-AMPKα and 671	  
p-ACC were then analyzed by immunoblotting. To analyze the levels of p-AMPKα 672	  
and p-ACC in liver, the freshly excised liver tissues were added with ice cold lysis 673	  
buffer (10 µl/mg liver weight), followed by homogenization and centrifugation as 674	  
described above. The lysates were then mixed with 2× SDS sample buffer and then 675	  
subjected to immunoblotting. Levels of total proteins and the levels of 676	  
phosphorylation of proteins were analyzed on separate gels and representative images 677	  
were shown. The band intensities on developed films were quantified using Image J 678	  
software (National Institutes of Health Freeware). 679	  
 680	  
Fluorescence microscopy 681	  
HEK293T infected with different fusion constructs of β1 were grown on glass 682	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coverslips in 6-well dishes and were cultured to 60-80% confluence. Cells were fixed 683	  
with 1 ml of 4% formaldehyde (diluted in PBS) at room temperature for 20 min. They 684	  
were rinsed twice with 1 ml PBS (room temperature) and then permeabilized with 1 685	  
ml of 0.1% Triton X-100 (diluted in PBS) for 5 min at 4 °C. Cells were rinsed twice 686	  
with 1 ml PBS, and were incubated with primary antibodies overnight at 4 °C. The 687	  
cells were then rinsed three times with 1 ml PBS, and then incubated with 688	  
Alexa-Fluor 594-conjugated anti mouse secondary antibody (Molecular Probes, cat. 689	  
A11032; diluted 1:100 in PBS) and Alexa-Fluor 488-conjugated anti-rabbit secondary 690	  
antibody (Molecular Probes, R37117; diluted 1:100 in PBS) for 8 hr at room 691	  
temperature in the dark. They were washed four times with 1 ml PBS, and then 692	  
mounted on glass slides using ProLong Diamond Antifade Mountant (Molecular 693	  
Probes, cat. P36970). Cells were imaged under a Zeiss LSM 780. Samples were 694	  
excited with an Ar gas laser (Zeiss, laser module LGK 7812) using a 488-nm laser 695	  
line for Alexa-Fluor 488 dye (green channel), and with a HeNe gas laser (Zeiss, LGK 696	  
7512 PF) using a 594-nm laser line for Alexa-Fluor 594 dye (red channel). Confocal 697	  
microscope images were taken with a 63× oil objective and representative images 698	  
were shown. The parameters, including ‘PMT voltage’, ‘Offset’, ‘Pinhole’ and ‘Gain’, 699	  
were kept unchanged between each image taken.  700	  
 701	  
CE-MS-based analysis of AMP, ADP, and ATP  702	  
Sample preparation for CE (capillary electrophoresis)-MS was carried out as 703	  
described previously75, 76, with some modifications. In general, each measurement 704	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required cells collected from a 10-cm dish (60-70% confluence) or 100 mg of liver 705	  
tissue. For analysis of metabolites, cells were rinsed with 20 ml of 5% mannitol 706	  
solution (dissolved in water) and instantly frozen in liquid nitrogen. Cells were then 707	  
lysed with 1 ml of methanol containing internal standards 1 [IS1 (Human Metabolome 708	  
Technologies, H3304-1002, 1:200), used to standardize the metabolite intensity and to 709	  
adjust the migration time], and were scrapped off from the dish. For analysis of 710	  
metabolites in liver, the fleshly excised tissue was freeze-clamped first, then washed 711	  
in pre-cooled 5% mannitol solution and grinded in 1 ml of methanol with 50 µM IS1. 712	  
The lysate was then mixed with 1 ml of chloroform and 400 µl of water by 20 s of 713	  
vortexing. After centrifugation at 15,000g for 15 min at 4 °C, 450 µl of aqueous phase 714	  
was collected and was then filtrated through a 5 kDa cutoff filter (Millipore, cat. 715	  
UFC3LCCNB-HMT) by centrifuging at 10,000g for 3 hr at 4 °C. Simultaneously, the 716	  
quality control (QC) sample was prepared by combining 100 µl of the aqueous phase 717	  
from each samples and then filtered. The filtered aqueous phase was then freeze-dried 718	  
in a vacuum concentrator and then dissolved in water containing internal standards 3 719	  
[IS3 (Human Metabolome Technologies, H3304-1104, 1:200), to adjust the migration 720	  
time]. 20 µl of re-dissolved solution was then loaded into an injection vial with a 721	  
conical insert for CE-TOF MS (Agilent Technologies 7100, equipped with 6224 mass 722	  
spectrometer) analysis. For quantification of AMP and ATP, [U-13C, 15N]AMP and 723	  
[U-13C, 15N]ATP were used to generate standard curves by plotting the ratios of 724	  
detected labelled AMP or ATP (areas) to the products of IS1 and IS3, against the 725	  
added concentrations of labelled AMP or ATP. The standard curve of [U-13C, 726	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15N]AMP was also used for quantification of ZMP, because of the structural similarity 727	  
between them. The amount of AMP, ZMP, and ATP were then estimated according to 728	  
equations generated from standard curves. The average cell volume, 2263 µm3, was 729	  
determined by Imaris 7.4.0 software (Bitplane) from the axial image stacks of 730	  
CDFA-SE labelled MEFs taken under Zeiss LSM780. 731	  
 732	  
HPLC-MS-based analysis of short-chain acyl-CoA 733	  
Procedure of preparing samples for HPLC-MS-based acyl-CoA analysis was identical 734	  
to that described in the CE-MS section, except that cells or liver tissues were rinsed in 735	  
PBS, and that 13C2:0-CoA (150 µg/l) and 13C3:0-CoA (200 µg/l) prepared in methanol 736	  
were added as internal standards. Some 800 µl of the aqueous phase of each sample 737	  
was collected after centrifugation at 15,000 g for 15 min at 4 °C and was lyophilized 738	  
in a vacuum concentrator. Samples were then re-dissolved in 20 µl of ice-cold 20% 739	  
methanol. Measurement of acetyl- and malonyl-CoAs was based on a previous study77 740	  
using a QTRAP (SCIEX, QTRAP 6500 plus) mass spectrometer interfaced with a 741	  
UPLC system (Waters, ACQUITY UPLC system). Some 5 µl of each sample were 742	  
injected onto an Acquity HSS T3 column (2.1 × 50 mm, 1.7 µm, Waters) attached to 743	  
an Acquity BEH C18 pre-column (2.1 × 5 mm, 1,7 µm, Waters). Mobile phases A and 744	  
B were water and acetonitrile, respectively (both contains 10 mM ammonium acetate 745	  
and 0.05% ammonium hydroxide). The column temperature was maintained at 30 °C 746	  
and autosampler temperature at 8 °C. The gradients were as follows: t = 0 min, 3% B; 747	  
t = 1 min, 3% B; t = 13 min, 15% B; t = 14.1 min, 100% B; t = 14.7 min, 100% B; t = 748	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14.71 min, 3% B; t = 17 min, 3% B. Mass spectrometer was run in positive mode with 749	  
multiple reactions monitoring mode (MRM), and declustering potentials (DP) and 750	  
collision energies (CE) were set at 200 V and 38 V, respectively (optimized using 751	  
13C2:0- and 13C3:0-CoA). The following transitions and retention time were used for 752	  
monitoring each compound: 812.0, 305.3, and 2.2 min for 13C2:0-CoA, 810.1, 303.1, 753	  
and 2.2 min for acetyl-CoA, 856.9, 350.2, and 0.8 min for 13C3:0-CoA, and 854.1, 754	  
347.1, and 0.8 min for malonyl-CoA. It should be noted that acyl-CoAs were 755	  
extremely easy to degrade even frozen at -80 °C, so no pause was taken during the 756	  
whole analytic process and no more than 6 samples were re-dissolved and kept in 757	  
autosampler at one time. 758	  
 759	  
Statistical analysis 760	  
1-way or 2-way ANOVA with post hoc analysis was used to compare values among 761	  
different experimental groups. For experiments with only two groups, a two-tailed 762	  
Student’s t test was used as specified in the figure legends. For ANOVA, the 763	  
homogeneity of variance was firstly tested by Levene’s test. If the results are similar, 764	  
the Tukey's test was preceded, and if not, the Games-Howell’s test was processed. 765	  
Similar procedures were followed when Student's t test was performed. No samples or 766	  
animals were excluded from the analysis. Tests were performed with SPSS Statistics 767	  
17.0 program, and p < 0.05 was considered statistically significant. Statistical 768	  
significance is shown as * p < 0.05, ** p < 0.01, *** p < 0.001; N.S., not significant. 769	  
 770	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Figure Legends 1007	  
 1008	  
Fig. 1 Basal AMP Is Sufficient for Activation of the Lysosomal Pool of AMPK. a 1009	  
Low glucose exclusively activates the lysosomal pool of AMPK in MEFs. MEFs were 1010	  
grown in full medium and then switched to DMEM containing reduced concentrations 1011	  
of glucose for 2 hr, or to DMEM lacking both glucose and glutamine (starvation for 1012	  
glucose plus glutamine, GS+QS). Cytosolic, lysosomal, and mitochondrial fractions 1013	  
were prepared following the methods described in “Materials and Methods”. 1014	  
Fractions were then subjected to analysis of p-AMPKα and p-ACC by 1015	  
immunoblotting using the indicated antibodies, followed by densitometry analysis. 1016	  
Statistical analysis results were shown in mean ± SD; *** p < 0.001, * p < 0.05, N.S., 1017	  
not significant by ANOVA, n = 3. b AMP:ATP and ADP:ATP ratios are not changed 1018	  
in MEFs in low glucose. Adenylate nucleotide ratios in MEFs treated as in (a) were 1019	  
measured by CE-MS. Results are mean ± SD; N.S., not significant by ANOVA, n = 3. 1020	  
c Starvation-induced AMPK activation in liver takes place on lysosome. Mice were 1021	  
fed ad libitum or starved for 16 hr, followed by fractionation of cytosol, lysosomes 1022	  
and mitochondria from liver homogenates, and subsequent immunoblotting using the 1023	  
indicated antibodies. d AMP/ATP and ADP/ATP ratios are unchanged in the liver of 1024	  
starved mice. Mice were fed or starved as in (c), freeze-clamped liver samples 1025	  
prepared, and AMP/ATP and ADP/ATP ratios measured by CE–MS. Results are 1026	  
mean ± SD, n = 6; N.S., not significant by Student’s t-test. e, f ACC1, but not ACC2, 1027	  
is phosphorylated in MEFs starved for glucose or in the liver of starved mice. MEFs 1028	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were glucose starved or severely starved as in (a), while mice were fed or starved as 1029	  
in (c). Endogenous ACC1 and ACC2 in MEFs (e) or mice livers (f) were individually 1030	  
immunoprecipitated, followed by immunoblotting. Statistical analysis data of 1031	  
experiments in (e) were shown in mean ± SD; *** p < 0.001, N.S., not significant by 1032	  
ANOVA, n = 3. g Phosphorylation of SREBP1c, TSC2, Raptor, HDAC4, ULK1, 1033	  
Beclin-1 and TBC1D1, but not MFF, is observed in low glucose. HEK293T cells or 1034	  
MEFs were incubated in DMEM medium with (25 mM) or without glucose for 2 hr, 1035	  
followed by analysis of phosphorylation levels of AMPK substrates as indicated. 1036	  
Statistical analysis data were shown in mean ± SD; * p < 0.05, ** p < 0.01, *** p < 1037	  
0.001, by ANOVA, n = 3. h AXIN1 and AXIN2 are functionally equivalent in the 1038	  
lysosomal pathway of AMPK activation in HEK293T cells. AXIN2-/- HEK293T cells 1039	  
and its wildtype control were infected with lentivirus expressing siRNA against 1040	  
AXIN1. Cells were starved for glucose for 2 hr and then lyzed, followed by 1041	  
immunoblotting. i Re-introduction of AXIN2 into AXIN1-/- MEFs restores glucose 1042	  
starvation-induced AMPK activation. AXIN1-/- MEFs (and its wildtype control) were 1043	  
infected with lentivirus expressing HA-tagged AXIN2. Cells were then starved for 1044	  
glucose for 2 hr, followed by immunoblotting. Experiments in this figure were 1045	  
performed three times, except (d) and (i) twice. See also Supplementary information, 1046	  
Fig. S1 1047	  
 1048	  
Fig. 2 Modest Increases in AMP Activate Cytosolic AMPK in an AXIN1-dependent 1049	  
Manner. a Glucose starvation activates both lysosomal and cytosolic AMPK in a 1050	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LAMTOR1-independent manner in HEK293 cells. HEK293 cells were infected with 1051	  
siRNA against LAMTOR1, and were deprived of glucose or both glucose and 1052	  
glutamine for 2 hr, followed by fractionation and immunoblotting. Statistical analysis 1053	  
data were shown on lower panel, in mean ± SD; N.S., not significant by ANOVA, n = 1054	  
3. b AXIN is required for glucose starvation-induced, cytosolic AMPK activation in 1055	  
HEK293 cells. Cells were infected with siRNA against AXIN1, followed by glucose 1056	  
starvation or severe nutrient starvation as in (a). P-AMPKα level was then determined 1057	  
by immunoblotting, followed by densitometry analysis, and the data were shown in 1058	  
mean ± SD; *** p < 0.001, * p < 0.05 by ANOVA, n = 3. c The AMP levels and 1059	  
AMP/ATP and ADP/ATP ratios are modestly increased in HEK293 cells, unlike 1060	  
MEFs, after glucose starvation. HEK293 cells were regularly cultured (Nor), starved 1061	  
for glucose for 2 hr (GS), or starved for both glucose and glutamine for 2 hr (GS+QS), 1062	  
followed by determination of concentrations (upper panel) and ratios (lower panel) of 1063	  
adenylate nucleotide by CE-MS. Results are mean ± SD; ** p < 0.01, *** p < 0.001 1064	  
by ANOVA, n = 3. d ACC1, but not ACC2, is phosphorylated in HEK293 cells after 1065	  
glucose starvation. Cells were starved as in (b), in which endogenous ACC1 and 1066	  
ACC2 were individually immunoprecipitated and analyzed by immunoblotting. 1067	  
Statistical analysis data were shown in mean ± SD; *** p < 0.001 by ANOVA, n = 3. 1068	  
e AICAR at low concentrations activates cytosolic AMPK as does moderately 1069	  
increased AMP. MEFs were treated with 0.6 mM AICAR for 2 hr, or starved for 1070	  
glucose or both glucose and glutamine for 2 hr, followed by fractionation and 1071	  
immunoblotting. f ACC1, but not ACC2, is phosphorylated in MEFs treated with low 1072	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concentrations of AICAR. MEFs were treated with AICAR or severely starved as in 1073	  
(e). The endogenous ACC1 and ACC2 were then individually immunoprecipitated 1074	  
and analyzed by immunoblotting. g, h AICAR at low concentrations activates 1075	  
cytosolic AMPK in an AXIN1-dependent, LAMTOR1-independent manner. AXIN1-/- 1076	  
MEFs (g) and LAMTOR1-/- MEFs (h) were treated with AICAR or severely starved as 1077	  
in (e), followed by fractionation and immunoblotting. i Knockout of AXIN1 blocked 1078	  
the association between LKB1 and AMPK under moderate AMP in MEFs. Cells were 1079	  
treated with 0.6 mM AICAR for 2 hr, followed by fractionation. Endogenous AMPKα 1080	  
from lysosomal and cytosolic fractions was then immunoprecipitated, and its 1081	  
interaction with AXIN1 and LKB1 was analyzed by immunoblotting with indicated 1082	  
antibodies. Experiments in (a), (b), (d), (g), (h) and (i) were performed three times, 1083	  
and the others twice. See also Supplementary information, Fig. S2 1084	  
 1085	  
Fig. 3 The Mitochondria-localized ACC2 Is Phosphorylated by AMPK Only after 1086	  
Severe Nutrient Stress. a Severe nutrient stress causes a full activation of AMPK in 1087	  
the cytosolic, lysosomal and mitochondrial pools. MEFs were starved for both 1088	  
glucose and glutamine for 2 hr, treated with 2 mM AICAR for 2 hr, or starved for 1089	  
glucose for 2 hr as a control, followed by fractionation and immunoblotting for 1090	  
p-AMPKα. Statistical analysis data were shown in mean ± SD; ** p < 0.01, N.S., not 1091	  
significant by ANOVA, n = 3. b The AMP levels, and ratios of AMP/ATP and 1092	  
ADP/ATP in MEFs under severe nutrient stress. Cells were treated with 2 mM 1093	  
AICAR or starved for glucose as in (a), in which adenylate concentrations (upper 1094	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panel) and nucleotide ratios (lower panel) were measured by CE-MS. Note that in the 1095	  
group of AICAR treatment, the total levels of AMP were composed of the amount of 1096	  
ZMP-converted AMP (estimated according to a previous study52) and that of 1097	  
endogenous AMP. Results are mean ± SD; *** p < 0.001 by ANOVA, n = 3. c Both 1098	  
ACC1 and ACC2 are phosphorylated in MEFs under severe nutrient stress. Cells were 1099	  
treated as in (a). The endogenous ACC1 and ACC2 were then individually 1100	  
immunoprecipitated and analyzed by immunoblotting. Statistical analysis data were 1101	  
shown in mean ± SD; *** p < 0.001, N.S., not significant by ANOVA, n = 3. d 1102	  
ACC1/2 in both cytosolic and mitochondrial pools can be phosphorylated in MEFs 1103	  
under severe nutrient stress. Cells were treated with AICAR or starved for glucose as 1104	  
in (a), followed by fractionation and immunoblotting for p-ACC. Statistical analysis 1105	  
data were shown in mean ± SD; *** p < 0.001, ** p < 0.01, N.S., not significant by 1106	  
ANOVA, n = 3. e ACC2 can only be phosphorylated in MEFs under severe nutrient 1107	  
stress. ACC1-/- and ACC2-/- MEFs were starved for glucose for 2 hr, treated with 0.6 1108	  
mM AICAR for 2 hr, or starved for both glucose and glutamine for 2 hr, followed by 1109	  
immunoblotting. f Levels of acetyl-coA and malonyl-CoA, the substrate and product 1110	  
respectively of ACC, in MEFs under different kinds of stress. Cells were starved or 1111	  
treated with AICAR as in (a), except that 20 µM TOFA (2-hr-treatment) was used as 1112	  
an additional control, followed by determining acetyl-coA and malonyl-CoA levels by 1113	  
HPLC-MS. Results are mean ± SD; *** p < 0.001, N.S., not significant by ANOVA, 1114	  
n = 3. g All pools of AMPK, in the cytosol, lysosome and mitochondria can be 1115	  
activated in liver of mice subjected to hepatic ischemia. Mice were anesthetized. The 1116	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left lateral and median lobes of liver were deprived of blood flow for 10 min by 1117	  
cross-clamping the hepatic artery and portal vein (described in EXPERIMENTAL 1118	  
PROCEDURES). Liver homogenates were then subjected to fractionation as in Fig. 1119	  
1c, followed by immunoblotting. h, i AMP/ATP and ADP/ATP ratios, acetyl-coA and 1120	  
malonyl-coA levels in livers from mice under starvation or hepatic ischemia. Mice 1121	  
were starved for 16 hr or subjected to hepatic ischemia (for 10 min), followed by 1122	  
measurement of AMP/ATP and ADP/ATP ratios by CE-MS (h) or acetyl-coA and 1123	  
malonyl-coA levels by HPLC-MS (i). Results are mean ± SD; *** p < 0.001 by 1124	  
Student’s t-test (h), ** p < 0.01, N.S., not significant by ANOVA (i), n = 6. j A 1125	  
schematic diagram showing the three fusion constructs of the β1 subunit (with 1126	  
modifications at the N-terminus) that allow AMPK to locate on lysosomal surface, 1127	  
mitochondrial outer membrane, or in cytosol. k ACC2 can only be phosphorylated by 1128	  
cytosol-localized and the mitochondrion-localized AMPK. AMPKβ-DKO HEK293T 1129	  
cells were infected with HA-tagged lyso-β1 (left panel), cyto-β1 (middle panel) and 1130	  
mito-β1 (right panel), respectively. Cells were then treated with 1 µM A-769662 for 2 1131	  
hr to allow full activation of AMPK, followed by fractionation and immunoblotting 1132	  
for analyzing p-AMPKα, or by immunoprecipitation and immunoblotting for 1133	  
analyzing p-ACC1 and p-ACC2. Experiments in (a), (c), (d), (e), (g) and (k) were 1134	  
performed three times, and the others twice. See also Supplementary information, Fig. 1135	  
S3, S4 1136	  
 1137	  
Fig. 4 Roles of AMP in the Hierarchical Activation of AMPK. a AMPKγ1-D317A 1138	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impairs glucose-starvation-induced AMPK activation. HA-tagged AMPK-γ1 and its 1139	  
D317A mutant were re-introduced into AMPKγ-TKO HEK293T cells. Cells were 1140	  
then deprived of glucose for 2 hr, followed by immunoblotting. b, c AMPKγ2-R531G 1141	  
blocks the phosphorylation of cytosolic and mitochondrial AMPK under moderate 1142	  
and high AMP levels. HA-tagged AMPK-γ2 and its R531G mutant were 1143	  
re-introduced into AMPKγ-TKO HEK293T cells. Cells were then deprived of glucose 1144	  
for 2 hr, followed by fractionation and immunoblotting for analyzing p-AMPKα (b), 1145	  
or by immunoprecipitation and immunoblotting for analyzing p-ACC1 and p-ACC2 1146	  
(c). Statistical analysis data were shown in mean ± SD; *** p < 0.001, * p < 0.05, 1147	  
N.S., not significant by ANOVA, n = 3. d Knockout of AK1 significantly dampens the 1148	  
activation of mitochondrial- and cytosolic-localized AMPK in high AMP conditions. 1149	  
MEFs with AK1 being knocked out were deprived of glucose or both glucose and 1150	  
glutamine for 2 hr, followed by fractionation and immunoblotting for analyzing 1151	  
p-AMPKα. Statistical analysis data were shown in mean ± SD; *** p < 0.001, ** p < 1152	  
0.01, * p < 0.05, N.S., not significant by ANOA, n = 3. e A simplified model 1153	  
depicting that the differentially compartmentalized pools of AMPK are activated with 1154	  
different dependencies on AXIN, and the severities of nutrient or energy stress. 1155	  
Glucose starvation, without increase of AMP levels, exclusively activates the 1156	  
lysosomal pool of AMPK through the AXIN-based pathway (u) which 1157	  
phosphorylates substrates including ACC1, SREBP1, TSC2, Raptor, HDAC4, ULK1 1158	  
and TBC1D1 to elicit early anti-anabolic roles. Moderately increased AMP levels, 1159	  
during the early phase of severe starvation or after treatment of low concentrations of 1160	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AICAR, activates cytosolic AMPK, in addition to the lysosomal AMPK (v), still 1161	  
dependent on AXIN. When AMP levels go up further as a result of severe starvation, 1162	  
ischemia, or treatment of high concentrations of AICAR, cytosolic AMPK (w) and 1163	  
mitochondrial AMPK (x) are activated independently of AXIN, leading to 1164	  
phosphorylation of ACC2 and MFF and accelerating catabolic activities, along with 1165	  
all the other substrates that can be phsophorylated at lower AMP levels. Of note, 1166	  
TSC2 and Raptor can be phosphorylated by all the four modes to respectively inhibit 1167	  
mTORC1 activity. Experiments in this figure were performed three times. See also 1168	  
Supplementary information, Fig. S4 1169	  
 1170	  
IB: p-AMPKα
AMPKα
Glc (mM)
Cytosol
25 10 5 3 1 0 0
+ + + + + + -Gln (4 mM)
Lysosome Mitochondrion TCL
MEFs
a
b
d Liver
Fed Starved
N.S.
Glc (mM) 0 1 3 5 10 25 GS+QS
N.S.AM
P:A
TP
AD
P:A
TP
MEFs
25 10 5 3 1 0 0
+ + + + + + -
25 10 5 3 1 0 0
+ + + + + + -
25 10 5 3 1 0 0
+ + + + + + -
p-A
MP
Kα
/
AM
PK
α
N.S.
***
***
N.S.
***
*
AM
P:A
TP
AD
P:A
TP
Fed ad lib Starved
Cytosol
Mitocho-
ndrion
TCL
Lysosome
IB: p-AMPKα
AMPKα
Liver
c
p-AMPKα
AMPKα
p-AMPKα
AMPKα
p-AMPKα
AMPKα
IB: p-ACC
ACC
Glc (mM)
IP: ACC1
25 10 5 3 1 0 0
+ + + + + + -Gln (4 mM)
25 10 5 3 1 0 0
+ + + + + + -
IP: ACC2
25 10 5 3 1 0 0
+ + + + + + -
TCL
MEFs
e
p-A
CC
/AC
C
***
N.S.
***
***
f
IB: p-SREBP1
SREBP1
p-Raptor
Raptor
p-TSC2
TSC2
p-HDAC4
HDAC4
p-MFF
MFF
p-ULK1
ULK1
HEK293T
p-TBC1D1
TBC1D1
QS
GS
AICAR (2 mM)
- + + -
- - + -
- - - +
g
MEFsp-Beclin-1Beclin-1 p-B
ec
lin
-1/
Be
cli
n-1
p-H
DA
C4
/
HD
AC
4
p-M
FF
/
MF
F
p-R
ap
tor
/
Ra
pto
r
p-S
RE
BP
1/
SR
EB
P1
p-T
BC
1D
1/
TB
C1
D1
p-T
SC
2/
TS
C2
p-U
LK
1/
UL
K1
HEK293T
- - + + - - + +
25 0 25 0 25 0 25 0
IB: p-AMPKα
AMPKα
p-ACC
ACC
Glc (mM)
AXIN1
siAXIN1
AXIN2+/+ AXIN2-/-
AXIN2
Tubulin
h
MEFs
IB: p-AMPKα
AMPKα
p-ACC
ACC
AXIN1
HA (AXIN2)
Tubulin
- - + + - - + +
25 0 25 0 25 0 25 0Glc (mM)
HA-AXIN2
AXIN1+/+ AXIN1-/-
i
IP: ACC1 IP: ACC2 TCL
Fed ad lib Starved Fed ad lib StarvedFed ad lib Starved
IB: p-ACC
ACC
Liver
Fig 1 
** ***
*** **
*** *
***
**
QS
GS
AICAR (2 mM)
- + + -
- - + -
- - - +
- + + -
- - + -
- - - +
- + + - + +
- - + - - +
siGFP siLAMTOR1
QS
GS
Mitochondrion
- + + - + +
- - + - - +
siGFP siLAMTOR1
Lysosome
- + + - + +
- - + - - +
siGFP siLAMTOR1
Cytosol
IB: p-AMPKα
AMPKα
- + + - + +
- - + - - +
siGFP siLAMTOR1
TCL
HEK293
a
- + + - + +
- - + - - +
siGFP siAXIN1
QS
GS
Mitochondrion
- + + - + +
- - + - - +
siGFP siAXIN1
Lysosome
- + + - + +
- - + - - +
siGFP siAXIN1
Cytosol
IB: p-AMPKα
AMPKα
- + + - + +
- - + - - +
siGFP siAXIN1
TCL
HEK293
b
c
d
- + + - + +
- - + - - +
siGFP siAXIN1
QS
GS
IB: p-ACC
ACC
IP: ACC1
- + + - + +
- - + - - +
siGFP siAXIN1
IP: ACC2
- + + - + +
- - + - - +
siGFP siAXIN1
TCL
HEK293
IB: p-AMPKα
AMPKα
QS
GS
AICAR (0.6 mM)
MitochondrionLysosomeCytosol TCL
- + - +
- - + -
- - - +
- + - +
- - + -
- - - +
- + - +
- - + -
- - - +
- + - +
- - + -
- - - +
IB: p-ACC
ACC
QS
GS
AICAR (0.6 mM)
TCLIP: ACC2IP: ACC1
- + - +
- - + -
- - - +
- + - +
- - + -
- - - +
- + - +
- - + -
- - - +
MEFs
MEFs
e
f
- + - - + -
- - + - - +
AXIN1+/+ AXIN1-/-
AICAR (0.6 mM)
GS
Mitochondrion
- + - - + -
- - + - - +
AXIN1+/+ AXIN1-/-
Lysosome
- + - - + -
- - + - - +
AXIN1+/+ AXIN1-/-
Cytosol
IB: p-AMPKα
AMPKα
- + - - + -
- - + - - +
AXIN1+/+ AXIN1-/-
TCL
- + - - + -
- - + - - +
LAMTOR1+/+LAMTOR1-/-
AICAR (0.6 mM)
GS
Mitochondrion
- + - - + -
- - + - - +
LAMTOR1+/+LAMTOR1-/-
Lysosome
- + - - + -
- - + - - +
LAMTOR1+/+ LAMTOR1-/-
Cytosol
IB: p-AMPKα
AMPKα
- + - - + -
- - + - - +
LAMTOR1+/+LAMTOR1-/-
TCL
MEFs
MEFs
g
h
i
Fig 2 
- + - +
AXIN1+/+AXIN1-/-
AICAR (0.6 mM)
Lysosome,
IP: AMPKα
TCL
Cytosol,
IP: AMPKα
IB: LKB1
AXIN1
AMPKα
LKB1
AXIN1
AMPKα
LKB1
AXIN1
AMPKα
MEFs
HEK293
AM
P:A
TP
AD
P:A
TP
**
***
Nor GS GS+QS
N.S.
HEK293
**
AM
P (
μM
)
AT
P (
μM
)
Nor GS GS+QS
N.S.
N.S.
N.S.
* *** *
*** ***
Fig 3 
MEFs
p-A
MP
Kα
/
AM
PK
α
IB: p-AMPKα
AMPKα
QS
GS
AICAR (2 mM)
MitochondrionLysosomeCytosol TCL
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
a b
IB: p-ACC
ACC
IP: ACC1 IP: ACC2 TCL
MEFsp
-A
CC
/AC
C
QS
GS
AICAR (2 mM)
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
c
IB: p-ACC
ACC
Mitochondrion Cytosol TCL
MEFsp
-A
CC
/AC
C
QS
GS
AICAR (2 mM)
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
d
IB: p-ACC
ACC
- + - +
- - + -
- - - +
AICAR (0.6 mM)
GS
QS
ACC2-/-ACC1-/-
- + - +
- - + -
- - - +
MEFs
e f
g
Cytosol Mitochondrion TCLLysosome
IB: p-AMPKα
AMPKα
Sham Ischemia Sham IschemiaSham Ischemia Sham Ischemia
Liverh i
j
k
TCLLyso
A-769662
IB: p-AMPKα
AMPKα
IB: p-AMPKα
AMPKα
IB: p-AMPKα
AMPKα
- +
TCLACC1 ACC2
A-769662
IB: p-ACC
ACC
IP
IB: p-ACC
ACC
Lyso-β1 Cyto-β1 Mito-β1
AMPKβ-DKO HEK293T AMPKβ-DKO HEK293T AMPKβ-DKO HEK293T
AMPKβ-DKO HEK293T AMPKβ-DKO HEK293T
LAMP2 AMPKβ1 HA TOMM20 AMPKβ1 HAAMPKβ1 HA
G2A G2A G2A
MEFs
AM
P (
μM
)
AT
P (
μM
)
AM
P:A
TP
AD
P:A
TP
AM
P:A
TP
AD
P:A
TP
Sham Ischemia
***
liver
***
***
MEFs
MEFs
Nor GS TOFA GS+QS
Ma
lon
yl-
Co
A 
lev
el
Ac
-C
oA
 le
ve
l N.S.
***
N.S.
liver liverM
alo
ny
l-C
oA
 le
ve
l
Ac
-C
oA
 le
ve
l
Sham
Ischemia
Starvation
**
N.S.
- + - + - +
Cyto TCL
A-769662 - +
Mito TCL
A-769662 - + - +
+ HA-Lyso-β1 + HA-Cyto-β1
- + - + - +
TCLACC1 ACC2
A-769662
IP
- + - +
+ HA-Mito-β1
IB: p-ACC
ACC
AMPKβ-DKO HEK293T
- +
TCLACC1 ACC2
A-769662
IP
- + - +
N.S.
** **
N.S.
**
***
N.S.
***
***
N.S.
**
ab
c
d
QS
GS - + + - + +
- - + - - +
AK1+/+ AK1-/-
Cytosol
- + + - + +
- - + - - +
AK1+/+ AK1-/-
Lysosome
- + + - + +
- - + - - +
AK1+/+ AK1-/-
Mitochondrion
- + + - + +
- - + - - +
AK1+/+ AK1-/-
TCL
IB: p-AMPKα
AMPKα
MEFs
e
IB: p-AMPKα
AMPKα
p-ACC
ACC
- + - +
WT D317A
GS
AMPKγ
AMPKγ-TKO HEK293T
IB: p-AMPKα
AMPKα
AICAR (0.6 mM)
GS - + - + - + - +
- - + - - - + -
- - - + - - - +
WT RG
Mitochondrion
WT RG
LysosomeCytosol TCL
HA-AMPKγ
AMPKγ-TKO HEK293T
IB: p-ACC
ACC
IP: ACC1 IP: ACC2 TCL
AMPKγ-TKO HEK293T
QS
Fig 4 
- + - + - + - +
- - + - - - + -
- - - + - - - +
- + - + - + - +
- - + - - - + -
- - - + - - - +
- + - + - + - +
- - + - - - + -
- - - + - - - +
WT RG WT RG
AICAR (0.6 mM)
GS - + - + - + - +
- - + - - - + -
- - - + - - - +
WT RG WT RGHA-AMPKγ
QS
- + - + - + - +
- - + - - - + -
- - - + - - - +
- + - + - + - +
- - + - - - + -
- - - + - - - +
WT RG
p-A
MP
Kα
/
AM
PK
α
p-A
MP
Kα
/
AM
PK
α
*** ****
***
** * **
***
MEFs
PDI
COXIV
Tubulin
IB: LAMP2
Lamin B1
MEFs MEFs
PDI
COXIV
Tubulin
IB: LAMP2
Lamin B1
PDI
COXIV
Tubulin
IB: LAMP2
Lamin B1
a b c
AICAR (mM)
GS - + - - + -
- - 0.6 2 - -
- - - - + -
- - - - - +
Nucleus TCL
QS
Etoposide
- + - - + -
- - 0.6 2 - -
- - - - + -
- - - - - +
IB: p-AMPKα
AMPKα
d
e
IB: p-AMPKα
QS
GS
AICAR (2 mM)
MitochondrionLysosomeCytosol TCL
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
f
IP: ACC1 IP: ACC2 TCL
IB: p-ACC
ACC
p-A
CC
/AC
C
QS
GS
AICAR (2 mM)
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
- + + -
- - - +
- - + -
g
HEK293T
IB: AXIN1
AXIN2
siGFPsiAXIN1
Tubulin
MEFs
WT AXIN1-/-
HEK293
siGFP siAXIN1
h
Nor GS GS+QS
HEK293T
AM
P:A
TP
AD
P:A
TPN.S.
N.S.
***
***
MEFs
HEK293T
AMPKα
HEK293T
***
N.S.
***
N.S.
*** **
N.S.
*
Supplementary information, Fig. S1. Basal AMP Is Sufficient for Activation of the Lysosomal Pool of AMPK
(a-c) Validation of methods for subcellular fractionation. MEFs were homogenized and subjected to fractionation of mitochondrion
(a), lysosome (b) and cytosol (c) following individual methods (described in “Materials and Methods” section). Fractions were then
analyzed by immunoblotting using the antibodies against LAMP2 (a lysosome marker), COXIV (a mitochondrion marker), PDI (an
ER marker), tubulin (a cytosol marker) and Lamin B1 (a nuclear marker), respectively.
(d) No nuclear AMPK activation can be detected under glucose starvation or severe nutrient stress. MEFs were starved for
glucose, glucose and glutamine, treated with 0.6 or 2 mM AICAR, or 20 μM etoposide (all for 2 hr). The nucleus fraction was then
prepared, followed by analysis of p-AMPKα levels by immunoblotting.
(e) Low glucose exclusively activates lysosomal pool of AMPK in HEK293T cells. Cells were starved for glucose, or for both
glucose and glutamine, or treated with 2 mM AICAR, all for 2 hr, followed by fractionation and immunoblotting.
(f) Adenine nucleotide ratios are unaltered in HEK293T cells after glucose starvation. Cells were starved as in (e), followed by
determination of adenylate nucleotide ratios by CE-MS. Results are mean ± SD; *** p < 0.001, N.S., not significant by ANOVA, n
= 3.
(g) ACC1, but not ACC2, is phosphorylated in in HEK293T cells starved for glucose. Cells were starved or treated with AICAR as
in (e). Endogenous ACC1 and ACC2 were individually immunoprecipitated, followed by immunoblotting.
(h, i) AXIN2 can be readily detected in HEK293T cells but not in MEFs, HEK293 cells and mouse liver. MEFs, HEK293 cells,
HEK293T cells (with AXIN1 knocked down/knocked out as controls) and mouse liver were lyzed and analyzed by immunoblotting.
Experiments in (a), (b), (c), (d), (f), (h), and (i) were performed twice and those in (e) and (g) three times.
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Supplementary information, Fig. S2. Modest Increases in AMP Activate Cytosolic AMPK in an AXIN1-dependent Manner
(a) ACC1, but not ACC2, is phosphorylated in HEK293 cells after glucose starvation in a LAMTOR1-independent manner. Cells were
glucose-starved or severely starved as in Fig. 2a, in which endogenous ACC1 and ACC2 were immunoprecipitated and analyzed by
immunoblotting.
(b) ZMP and AMP levels in MEFs treated with AICAR. MEFs were treated with AICAR at indicated concentrations for 2 hr, levels of the
endogenous AMP (top panel), AICAR-generated ZMP (middle panel) were then determined by CE-MS, and the combined AMP levels
are shown in the bottom panel. Results are mean ± SD; *** p < 0.001 by ANOVA, n = 3.
(c-d) Phosphorylation of ACC1 by low concentrations of AICAR is dependent on AXIN1, but not LAMTOR1. AXIN1-/- MEFs (c) and
LAMTOR1-/- MEFs (d) were treated with AICAR or severely starved as in Fig. 2e, followed by immunoprecipitation of ACC1 or ACC2,
and analyzed by immunoblotting.
(e) Moderate levels of AMP significantly promotes the phosphorylation of AMPK by LKB1 in vitro in an AXIN1-dependent manner.
Bacterially expressed and purified AMPK (800 ng) was incubated with active LKB1/MO25/STRAD complex (200 ng) at 32 °C, 15 min
in a kinase buffer containing 5 mM ATP with or without 60 μM AMP and 1 μg of AXIN. Phosphorylation of AMPK was determined by
immunoblotting.
All experiments were performed twice except for that in (a) three times.
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Supplementary information, Fig. S3. The Mitochondrion-localized ACC2 Is Phosphorylated by AMPK Only after Severe
Nutrient Stress
(a-c) ACC2 is a mitochondrion-residential protein. MEFs were homogenized and subjected to fractionation of mitochondrion (a),
lysosome (b) and cytosol (c). Fractions were then analyzed by immunoblotting using antibodies indicated. Note that neither
ACC1 nor ACC2 could be detected on the lysosomal fraction.
(d) Validation of ACC1-/- and ACC2-/- MEFs, and the specificity of antibodies against ACC1 and ACC2. MEFs with ACC1 or
ACC2 knocked out, or wildtype MEFs as a control, were lyzed and immunoprecipitated using antibodies against ACC1 and
ACC2, respectively. The immunoprecipitates, along with the total lysates, were analyzed by immunoblotting.
(e) Both ACC1 and ACC2 can be phosphorylated in the liver of mice after hepatic ischemia. Mice were anesthetized, and the left
lateral and median lobes of the liver were deprived of blood flow as in Fig. 3g. Liver samples were then homogenized and
immunoprecipitated for ACC1 and ACC2, respectively, followed by immunoblotting.
(f, g) Knockout of AXIN1 does not affect the activation of mitochondrion- and cytosol-localized AMPK, and the phosphorylation
of ACC2 in high AMP conditions. MEFs with AXIN1 knocked out were deprived of glucose or both glucose and glutamine for 2
hr, followed by fractionation and immunoblotting for analyzing p-AMPKα (f), or by immunoprecipitation and immunoblotting for
analyzing p-ACC1 and p-ACC2 (g).
(h, i) Knockout of LAMTOR1 does not affect the activation of mitochondrion- and cytosol-localized AMPK, and the
phosphorylation of ACC2 in high AMP conditions. MEFs with LAMTOR1 knocked out were deprived of glucose or both glucose
and glutamine as in (f), followed by analyzing p-AMPKα (h), or p-ACC1 and p-ACC2 (i).
All experiments were performed twice except for that in (e) three times.
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Supplementary information, Fig. S4. Roles of AMP in the Hierarchical Activation of AMPK
(a) Generation and validation of AMPKβ-DKO HEK293T cells. The strategy to generate AMPKβ-DKO HEK293T cells was
shown on left panel. For validation, HEK293T cells with AMPKβ1 and AMPKβ2 knocked out were lyzed, followed by analyzing
protein levels of AMPKβ1 and AMPKβ2 by immunoblotting using an antibody against both isoforms (shown on right panel).
(b) The expressed proteins of fusion constructs of the β1 subunit are effectively assembled into heterotrimeric AMPK
complexes. AMPKβ-DKO HEK293T cells were infected with HA-tagged lyso-β1, cyto-β1 and mito-β1, respectively. Cells were
lyzed, followed by immunoprecipitation with antibody against HA tag, and then subjected to immunoblotting using antibodies
indicated.
(c) Validation of the subcellular localization of the β1-fusion constructs. AMPKβ-DKO HEK293T cells were infected with the lyso-
β1 and mito-β1 fusion constructs, followed by immunofluorescent staining using antibodies indicated.
(d) A-769662 successfully causes activation of AMPK in AMPKβ-DKO HEK293T cells re-introduced with AMPKβ1. Cells were
treated with 1 μM A-769662 for 2 hr, and then by fractionation and immunoblotting for analyzing p-AMPKα (left panel), or by
immunoprecipitation and immunoblotting for analyzing p-ACC1 and p-ACC2 (right panel).
(e, f) Generation and validation of AMPKγ-TKO HEK293T cells and AK1-/- MEFs. Strategies to generate the two lines of cells
were shown on left of each panel, with validation of each cell line by immunoblotting using antibodies indicated (shown on right
of each panel).
(g) Knockout of AK1 significantly dampens the phosphorylation of ACC2 in high AMP conditions. MEFs with AK1 being knocked
out were deprived of glucose or both glucose and glutamine for 2 hr, followed by immunoprecipitation and immunoblotting for
analyzing p-ACC1 and p-ACC2.
Experiments in (d) were performed three times and others twice.
